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Unlike the majority of actinomycete secondary metabolic pathways, the
biosynthesis of peptidoglycan glycosyltransferase inhibitor moenomycin in
Streptomyces ghanaensis does not involve any cluster-situated regulators
(CSRs). This raises questions about the regulatory signals that initiate and sus-
tain moenomycin production. We now show that three pleiotropic regulatory
genes for Streptomyces morphogenesis and antibiotic production—bldA, adpA
and absB—exert multi-layered control over moenomycin biosynthesis in
native and heterologous producers. The bldA gene for tRNALeuUAA is required
for the translation of rare UUA codons within two key moenomycin bio-
synthetic genes (moe), moeO5 and moeE5. It also indirectly influences
moenomycin production by controlling the translation of the UUA-containing
adpA and, probably, other as-yet-unknown repressor gene(s). AdpA binds
key moe promoters and activates them. Furthermore, AdpA interacts with the
bldA promoter, thus impacting translation of bldA-dependent mRNAs—that
of adpA and several moe genes. Both adpA expression and moenomycin pro-
duction are increased in an absB-deficient background, most probably
because AbsB normally limits adpA mRNA abundance through ribonucleolytic
cleavage. Our work highlights an underappreciated strategy for secondary
metabolism regulation, in which the interaction between structural genes and
pleiotropic regulators is not mediated by CSRs. This strategy might be relevant
for a growing number of CSR-free gene clusters unearthed during actinomycete
genome mining.
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22. Introduction
Moenomycins (Mms) are a small family of secondary metab-
olites of actinomycete origin that display a number of
remarkable traits in terms of their chemistry and biology
[1]. Classified as phosphoglycolipids, they result from a
unique assembly of glycoside- and isoprene-derived moieties
bridged by 3-phosphoglyceric acid—an unprecedented
building block in secondary metabolism (SM). Moenomycins
strongly interfere with the growth of mainly Gram-positive
bacteria, including VRE and MRSA pathogens, through
direct inhibition of peptidoglycan glycosyltransferases
(PGTs). High potency of these antibiotics and their unique
mode of action explain much of the industrial and academic
interest in them. We have recently identified genes for moe-
nomycin production (moe gene cluster) by Streptomyces
ghanaensis ATCC14672 and harnessed them for generation
of a number of useful phosphoglycolipid analogues [2]. How-
ever, moenomycin production by either S. ghanaensis or
heterologous hosts must be significantly increased before
combinatorial biosynthesis can be a reliable source of novel
moenomycins for biological tests or chemical modifications.
We therefore set out to explore the regulation of moenomycin
production by S. ghanaensis, with the ultimate goal of using
the gained knowledge for strain improvement.
In the vast majority of studied cases, the transcriptional
regulators of actinomycete SM gene clusters form a two-
tiered network, with genes for cluster-situated regulators
(CSRs) and global (or pleiotropic) regulators scattered over
the genome and unlinked to SM pathways [3,4]. Global regu-
lators affect the expression of more than one SM pathway by
modulating the expression of CSR genes. SM pathways often
have more than a single associated CSR, in which case one of
the CRSs is an ultimate regulator of antibiotic production
(responsible for activation of structural antibiotic biosynthesis
genes), while others may act either singularly, on the ultimate
regulatory gene, or pleiotropically, on unrelated and
unlinked genes. It should be emphasized that ‘topology-
based’ classification of regulators (cluster-situated versus
global) does not predict function. That is, a CSR gene may
encode any of the following: (i) an ultimate regulator; (ii) a
true pleiotropic regulator [5] or ultimate regulator with
‘cross-talk’ properties [6]; or (iii) a regulator of a distal gene
cluster [7]. As one of the hallmarks of actinomycete SM
gene clusters, CSRs have attracted the interest of researchers,
particularly as a tool to develop antibiotic overproducers, and
they are often considered an essential layer of transcriptional
control over secondary metabolite production [8].
In contrast to the model described above, moenomycin
biosynthesis does not involve CSRs [9]. No CSR genes are
found in the moe cluster; the presence of essential moenomy-
cin-specific regulatory gene(s) elsewhere in the S. ghanaensis
genome is unlikely given that we were able to recreate moe-
nomycin production in several heterologous hosts [10].
Although CSR-free SM gene clusters in actinomycetes have
been considered the exception rather than the rule [11,12],
the number has increased steadily as numerous whole
genomes have been sequenced and analysed [13–16]. These
gene clusters represent a poorly understood archetype of
regulation of actinomycete SM, where CSRs are not involved.
In silico analysis of moe genes revealed the presence of TTA
leucine codons in two key moe genes, moeO5 and moeE5.
TTA is the rarest codon in actinobacteria [17] and, instreptomycetes, it is generally found in genes with auxiliary
functions (SM, aerial mycelium and spore formation, cryptic).
In Streptomyces coelicolor, mature tRNALeuUAA (specified by
bldA gene) is only formed during late stationary growth,
defining the onset of hyphae and antibiotic production
[18,19]. BldA regulation occurs via the presence of UUA
codons within CSR genes [20]. Recent work on ipomicin bio-
synthesis has provided initial evidence that bldA also
regulates the translation of structural SM genes [21]. We
hypothesize that bldA regulates moenomycin production at
the level of translation of mRNA of the key structural moe
genes. However, it is unlikely that bldA is the only regulator
of moenomycin production given the importance of tran-
scriptional control over SM (vide supra). Indeed, our
previous moe promoter titration studies pointed to the exist-
ence of transcriptional activator(s) of moe gene expression
[10]. In this study, we show that AdpAgh, an S. ghanaensis
orthologue of well-known S. coelicolor and Streptomyces gri-
seus master regulator AdpA [22–24], is an important and
direct activator of moe gene expression. The translation of
UUA-containing adpAgh mRNA is dependent on bldA-
encoded tRNA, although this dependence is not absolute.
Finally, we provide circumstantial evidence that AdpAgh
expression is regulated at the posttranscriptional level
through the action of the absBgh gene, encoding an orthologue
of S. coelicolor RNase III [25]. Together these data outline the
involvement of three interacting global regulatory genes,
absB–adpA–bldA, in control of a CSR-free secondary meta-
bolic pathway. The first gene, absB, directly regulates adpA
expression, bldA regulates the translation of both adpA and
moenomycin structural genes and adpA directly influences
moenomycin production. The regulatory influence of these
genes on moenomycin production is effective in S. ghanaensis
as well as several heterologous hosts. Our data and data from
recent literature allow us to propose that AdpA and BldA
may constitute a central regulatory component relevant to
many SM pathways lacking cluster-situated, pathway-
specific regulatory genes.3. Results
3.1. In silico analysis of Streptomyces ghanaensis
genome suggests the involvement of AdpA
in moenomycin production
Recent studies portrayed the transcription factor AdpA as
one of the most versatile regulators of Streptomyces biology
[24,26–29], including the expression of CSR-free secondary
metabolic gene clusters [16]. In S. coelicolor and S. griseus,
AdpA is known to influence other regulators, such as
tRNALeuUAA (BldA) and RNaseIII (AbsB). The latter regulates
AdpA abundance via ribonucleolytic cleavage of its mRNA.
As the moenomycin biosynthetic cluster does not contain any
specific regulatory genes, it is an excellent test bed to investi-
gate the possibility of combined SM regulation from AdpA,
AbsB and BldA. Our laboratory previously identified an
orthologue of absB in S. ghanaensis [10]. The absB-containing
chromosomal regions of S. coelicolor and S. ghanaensis are syn-
tenous. Presumably, absBgh belongs to the transcriptional unit
which comprises three genes: SSFG_02131.1, SSFG_02130.1
and SSFG_02129.1 (absBgh) (figure 1).
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Figure 1. Fragments of S. ghanaensis genome relevant to this study. Triangles indicate position of AdpA-binding sites as predicted in silico. Respective score values are
given near the binding sites. (a) The adpAgh-containing region with the adjacent genes. The distance between start and stop codons is shown. (b) Gene bldAgh with its
promoter region. The putative start of mature tRNA is shown. (c) Operon containing absBgh and constructs used for complementation of S. ghanaensis DabsBgh mutant.
(d ) Positions of high-scoring AdpAgh-binding sites within intergenic regions of moe cluster 1 studied in this work. The distance between start and stop codons is shown.
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Figure 2. Levels of moenomycin production by various S. ghanaensis strains.
Column labels: wt, DadpA—wild-type and adpAgh null mutant, respectively;
wt adpA—wild-type strain overexpressing adpAgh; DbldA—bldAgh-minus
mutant; wt bldA—wild-type strain overexpressing bldAgh; DabsB—
absBgh-minus mutant; DabsB absB-exp—absBgh-minus mutant expressing
plasmid for complementation pSOKEabsBgh-exp; wt absB-exp—wild-type
strain overexpressing absBgh.
rsob.royalsocietypublishing.org
Open
Biol3:130121
3In our in silico analysis [10] of S. ghanaensis, we identified
an AdpA orthologue in S. ghanaensis and designated it as
adpAgh. The coding sequence of adpAgh contains one TTA
codon (figure 1), at the same position as other adpAgh ortho-
logues [23,30–32]. Genes for several AdpAgh paralogues are
present in the S. ghanaensis genome (see the electronic sup-
plementary material, table S1). Additionally, a single copy
of the tRNALeuUAA gene was identified in the S. ghanaensis
genome (designated as bldAgh; figure 1).
Wemined the promoter regions of adpAgh, bldAgh, absBgh and
moe clusters for the presence of AdpA operator sequences [33].
As expected, such sequences were revealed within adpAghp
and bldAghp (figure 1). AdpA operator-like sites were identified
within many intergenic regions of the moe cluster 1 (data not
shown). Particularly, promoter regions of the key genes moeE5,
moeK5 and moeO5, responsible for production of the earliest
monosaccharide MmA intermediate [2], contain three, two
and one such sites, respectively (figure 1). The presence of an
AdpA orthologue in the S. ghanaensis genome and its respective
operator sequences within the moe cluster indicated that it may
have a role in the regulation of moenomycin production.
3.2. Moenomycin production is completely abolished in
Streptomyces ghanaensis adpA and bldA mutants,
and increased in the absB mutant
Deletion of adpAgh in the S. ghanaensis chromosome comple-
tely abolished moenomycin production, as determined by
LC-MS (figure 2) and bioassays. No mass peaks correspond-
ing to the earliest known moenomycin precursors [2] were
found in the extracts of adpAgh mutant (DadpAgh), showing
that moenomycin production was blocked at the initial first
steps. Knockout of adpAgh had a significant influence on the
morphological development S. ghanaensis. On solid media,a phenotype of S. ghanaensis DadpAgh resembled that of the
‘bald’ (bld) mutants described for streptomycetes (figure 3
and [34]). AdpA proteins in other species are key develop-
mental regulators, and their deletion has been reported to
lead to substantial morphological defects [26,32,35].
The moenomycin production and morphology in the
DadpAghwere restored to the wild-type state upon introduction
of an intact copy of adpAgh (plasmid pSETadpA-exp). Insertion
of an extra copy of adpAgh, under the control of a strong
constitutive promoter ermEp (plasmid pTESadpA-exp),
DadpA
pSETadpA-exp
ATCC14672
DbldA
pSET152bldA
DabsB
pSOKEabsBgh-expATCC14672
DadpA
DabsB
DbldA
(b)(a)
Figure 3. Lawns of S. ghanaensis mutants described in this study. (a) Wild-type S. ghanaensis ATCC14672, S. ghanaensis DabsBgh, S. ghanaensis DbldAgh and
S. ghanaensis DadpAgh (clockwise from the top left) were grown on TSB agar medium. (b) Respective mutants carrying plasmids for complementation,
pSOKEabsBgh-exp, pSET152bldA and pSETadpA-exp.
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4caused a 2.5-fold increase in moenomycin production
compared with the control strain (figure 2).
Like theDadpAgh,S. ghanaensisDbldAghdidnot produceMmA
or any of its intermediates (figure 2). Deletion of bldAgh im-
paired morphological development of S. ghanaensis (figure 3); in
particular, aerial mycelium formation was considerably delayed
compared with the wild-type strain (figure 3).
The introduction of a native copy of bldAgh into DbldAgh
(plasmid pSETbldA) restored the moenomycin production
and normal timing ofmorphogenesis, implying that theDbldAgh
phenotype is solely due to the absence of tRNALeuUAA. The
introduction of a second copy of bldA (pSET152bldA) into
the wild-type strain led to a slight (1.6-fold on average) but
reproducible increase in moenomycin production (figure 2).
The transcription and translation of several moe genes was
analysed in further detail to determine whether the bldA
mutation affected moenomycin production directly (by block-
ing the translation of UUA-containing moeO5 and moeE5
mRNAs) or indirectly (by arresting adpAgh expression). Semi-
quantitative RT-PCR analysis of moeO5, moeE5 and moeGT4
showed that their transcription was not decreased in DbldAgh;
in fact, it appeared to be increased (figure 4). Western blots
revealed that MoeE5 protein is present in the cell-free lysate
of the wild-type strain, but not in that of DbldAgh (figure 4),
indicating a direct regulatory influence on the expression of
TTA-containing moe genes by tRNALeuUAA.
The RNase III-deficient mutant (DabsBgh) produced on
average 2.7 times more moenomycin compared with theparental strain (figure 2). On solid media, DabsBgh differed
subtly from the wild-type (figure 3). Chromatograms of the
methanol extracts from the three aforementioned mutants
and the wild-type demonstrated little qualitative difference
beyond the moenomycin-related peaks (see the electronic sup-
plementary material, figure S1). Nevertheless, new mass peaks
seemed to occur in both DbldAgh and DadpAgh, and one peak
disappeared in DadpAgh extracts; detailed characterization of
these peaks was not pursued.
Bioinformatic analysis indicated that absBgh and two
upstream genes (SSFG_02131.1 and SSFG_02130.1) are sep-
arated by 2 and 19 bp, indicative of transcriptional operon
organization (figure 1). For complementation of S. ghanaen-
sis DabsBgh, a series of integrative plasmids with different
portions of this putative operon were constructed (for
details, see §5). Only the plasmid containing absBgh in cis
with the two upstream genes (pSOKabsBgh-III; figure 1)
decreased moenomycin production to the wild-type level,
suggesting that the absBgh is the last gene in a tricistronic
message. Additional complementation experiments were
designed to confirm that absBgh alone is sufficient to restore
the wild-type phenotype. absBgh under the control of ermEp
(pSOKEabsBgh-exp) was integrated into the S. ghanaensis
DabsBgh chromosome, and the resulting strain produced 2.5
times less moenomycin than the wild-type strain. Introduc-
tion of the same plasmid (pSOKEabsBgh-exp) into the
wild-type strain resulted in significantly decreased antibiotic
biosynthesis (figure 2).
(a)
(b)
C- GT4 O5 E5
WT
MoeE5
WT
DbldAgh
DbldAgh
Figure 4. The bldAgh gene directly affects translation of moeE5. (a) RT-PCR
analysis of moeE5, moeO5 and moeGT4 transcription in S. ghanaensis wild-
type (WT) and bldA-deficient (DbldAgh) strains. Lane C-, negative control
(rrnA amplification from RNA sample in absence of RT). (b) Western blot
analysis of cell-free lysates from WT and DbldAgh strains. The lysates were
obtained from mycelium harvested in moenomycin production phase (TSB,
72 h) and probed with anti-MoeE5 rabbit serum (raised as described in §5).
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53.3. GusA reporter systems reveal the interactions
of regulators with moe genes and each other
The recently described b-glucuronidase (GusA) reporter
system [36] was applied to investigate the functional connec-
tion between the aforementioned pleiotropic regulators and
moe genes. First, we measured transcription from the promoter
of key structural genemoeE5 (moeE5p) in all of the S. ghanaensis
mutants. The wild-type strain had relatively high levels of
transcription from moeE5p (see, for comparison, the activity
of other SM gene promoters [36]), but we failed to detect
transcription in the DadpAgh strain (figure 5). The moeE5 tran-
scription was increased more than twofold and threefold
from wild-type levels in S. ghanaensis DabsBgh and DbldAgh
strains, respectively (figure 5), in agreement with RT-PCR
data (figure 4). While the pattern of moeEp activity in DadpAgh
and DabsBgh is as anticipated [25], increased levels of moeE5p
transcript in theDbldAgh are somewhat unexpected. Aplausible
explanation is that moeE5p might be a target of an as-yet-
unknown repressor(s) positively regulated by BldA, in which
case the deletion of bldA would remove the repressive signal.
To further delineate the involvement of bldAgh in the transla-
tional regulation of moenomycin production, we analysed
GusA activity of translational fusions of gusA to moeE5 (plas-
mid pmoeE5transl) and adpAgh in a DbldAgh background. We
found no GusA activity in DbldAgh carrying moeE5–gusA
fusion (figure 6), underscoring the essentiality of bldAgh fortranslation of the two UUA codons in moeE5 mRNA. Surpris-
ingly, GusA activity was detected in the DbldAgh strain
carrying adpAgh–gusA fusion, although it was much weaker
(15-fold) than that in wild-type strain (figure 6). This obser-
vation can be attributed to mistranslation of adpAgh UUA
codon in the absence of tRNALeuUAA [37,38]. As the expression
ofAdpA in other cases has been shown to be strictly dependent
on BldA [23,32,39], our data set a precedent for this important
group of pleiotropic activators.
Next, we analysed adpAghp transcription. In comparison to
the wild-type strain, adpAghp levels (figure 5) increased 2.3-fold
in S. ghanaensis DabsBgh and were almost undetectable in the
DadpAgh strain (figure 5). We also measured the level of trans-
lation when adpAghp and the entire adpAgh genes were fused to
gusA (padpAtransl; see §5) and found it in DabsBgh to be double
that of wild-type (figure 6). Thus, AdpAgh acts as a positive
activator of its own expression and its activity is increased in
the absence of ribonucleolytic activity of AbsBgh. This con-
clusion is supported by observations in other streptomycetes
[25,40]. Similar to our moeE5p data, adpAghp activity was also
significantly increased in the DbldAgh strain (figure 5),
suggesting the existence of an unidentified bldA-dependent
repressor(s) of AdpAgh-regulated promoters.
There was no difference between absBghp transcriptional
activity in DadpAgh and wild-type strains, indicating that
AdpAgh does not influence the transcription of absBgh.
At the same time, we revealed almost complete cessation
of bldAgh transcription in the DadpAgh strain (figure 5).3.4. Adpagh interacts with promoters of bldAgh, adpAgh
and key moe genes
The GusA reporter data suggested that AdpAgh is a transcrip-
tional activator that regulates its own expression as well as
that of bldAgh and moe genes. To test this, we set out to demon-
strate AdpAgh binding to moeO5, moeK5, moeE5, bldAgh and
adpAgh promoter regions using electrophoretic mobility shift
assay (EMSA). A C-terminally His6-tagged derivative of
AdpAgh was overexpressed in Escherichia coli and purified to
homogeneity (see the electronic supplementary material,
figure S2). Increasing amounts of AdpAgh-His were incubated
with radiolabelled DNA probes corresponding to the promoter
regions of interest, and the complexes were separated by native
gel electrophoresis. Purified AdpAgh-Hiswas bound to the pro-
moter regions of moeO5, moeK5, moeE5, bldAgh and adpAgh in
quantities as low as 1.1–11.0 pmol. Increasing concentrations
of AdpAgh resulted in more than one protein–DNA complex
for moeO5p and moeK5p (figure 7), in agreement with multiple
AdpA-binding sites predicted for these promoters in silico.
While bioinformatics analysis predicted three putative AdpA-
binding sites within moeE5p, only one shifted band was
presented in the case of moeE5p. Unlabelled adpAgh promoter
competed with the radiolabelled one for AdpAgh (see the
electronic supplementary material, figure S3), while a non-
specific DNA fragment (the SCO3812 promoter region) was
not recognized by AdpAgh (see the electronic supplementary
material, figure S4).
AdpAgh formed three different bldAghp–AdpAgh com-
plexes suggesting the presence of multiple AdpA-binding
motifs within bldAghp. Increasing concentrations of AdpAgh
caused a transition from multiple bands to a single retarded
band, suggesting that above a certain AdpAgh concentration,
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Figure 5. Transcriptional activity of selected promoters in S. ghanaensis DabsB, DbldA and DadpA strains. WT, DabsB, DbldA and DadpA correspond to wild-type,
absBgh, bldAgh and adpAgh null mutant strains, respectively, of S. ghanaensis expressing gusA from different promoters. The moeE5p, adpAp, absBp and bldAp
correspond to promoters of moeE5, adpAgh, absBgh and bldAgh, respectively.
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Figure 6. Translation of AdpAgh and MoeE5 is strongly affected on bldAgh-
minus background. WT, DabsB and DbldA correspond to wild-type,
absBgh and bldAgh null mutant strains, respectively, of S. ghanaensis expres-
sing gusA fused to tested genes along with their promoters. adpA and moeE5
correspond to genes adpAgh and moeE5, respectively. As a negative control,
promoterless versions of the above genes were fused to gusA and introduced
into respective strains; these constructs had marginal or no GusA activity.
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6all AdpA operators will be occupied by the recombinant
protein. Finally, we confirmed that AdpAgh binds to its
own promoter (figure 7). Low concentrations of AdpAgh
(4.4 pmol) caused the appearance of intermediate nucleopro-
tein complexes, whereas saturation of the reaction mixture
with AdpAgh resulted in the formation of single band.3.5. Absb, AdpA and BldA are important for
moenomycin production by heterologous hosts
Previously, we demonstrated the successful expression of moe
clusters in different streptomycetes [9,10]. To investigate
whether the regulatory network we discovered in S. ghanaensis
also operates in these heterologous hosts, we analysed the
moenomycin production of the strains of S. coelicolor and
Streptomyces lividans impaired in adpA, absB and bldA genes.
To determine the level of moenomycins biosynthesis on a
DabsB-background, a cosmid moeno38-5 [10] carrying the main
part ofmoe cluster 1 anddirecting theproductionof nosokomycin
B2 (NoB2)was introduced into S. coelicolorDabsB strain J3410 [41].
S. coelicolor J3410 moeno38-5þwas grown in parallel with a con-
trol strain S. coelicolor M145 moeno38-5þ and NoB2 was
quantified. On average, J3410 moeno38-5þ accumulated 20%
less biomass than M145 moeno38-5þ and produced three times
less NoB2 compared with the control strain (figure 8). These
data correlate with the results of reporter experiments, where
we observed a 1.5-fold decrease in moeE5 transcription in a
DabsBgh strain compared with a control M145 strain (data not
shown). Our results suggest that the AbsB RNase III-mediated
0 0 0 01.1 4.4 11 11 111122 22 222244 44 44440 11 22 4488
free
bound
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free
bound
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Figure 7. AdpAgh interacts with promoter of its own gene (a), bldAgh (b) and several moe genes (c). EMSA showing binding of purified AdpAgh to various promoter
regions comprising in silico-predicted AdpA-binding sites. moeO5p, moeK5p, moeE5p, adpAghp and bldAghp correspond to promoter regions of moeO5, moeK5,
moeE5, adpAgh and bldAgh genes, respectively. Bands corresponding to protein–DNA complexes (bound) and free DNA (free) are indicated. The final amount
of AdpAgh (pmol) is indicated above each line.
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Figure 8. Levels of nosokomycin B1 production by various streptomycetes
expressing cosmid moeno38-5. Column labels: M145, J3410 and M851—
wild-type, rnc (absB)-minus and bldH (adpA)-minus mutants of S. coelicolor,
respectively; 1326 and J1725—wild-type and bldA null mutant of S. lividans,
respectively.
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7regulatory pathway is important for moenomycin production
even in other streptomycete heterologous hosts.
Next, we tested NoB2 production in adpA-deficient
S. coelicolor M851 and bldA-deficient S. lividans J1725 strains.
Mutant and parental strains carrying cosmid moeno38-5
did not differ in growth rate, but NoB2 production was
completely abolished (figure 8). No moeE5p activity was
revealed in S. coelicolor M851. NoB2 production was restored
to M851 and J1725 upon introduction of adpAgh and bldAgh,
respectively (data not shown).4. Discussion
The vast majority of natural product biosynthetic gene clusters
do contain one or more CSR genes. Expression of the latter is
shown in many cases to be dependent on global pleiotropic
regulators, for example AdpA [26,42]. Once produced, CSR
proteins directly activate the transcription of structural biosyn-
thetic genes [3,4,43]. However, a growing body of data suggest
that cluster-situated layers of regulation are not an obligatory
component of actinomycete secondary metabolic pathways.
The elucidation of the genetic organization of the erythromycin
biosynthetic cluster in the early 1990s provided the firstevidence of an SM pathway lacking CSRs [11,12,44]. The list
of ‘CSR-free’ gene clusters continues to grow; they direct the
production of secondary metabolites, as chemically diverse
as polyketides (erythromycin), both ribosomal and non-
ribosomal peptides (thiostrepton, albonoursin, pacidamycins)
[45,46], nucleoside analogues, phosphoglycolipids [1,14,15,
47,48] and acarbose-like natural products [49,50].
It is important to understand whether the expression of
different ‘CSR-free’ gene clusters has a common mechan-
ism(s) or principle of regulation. In this study, we show
that expression of one such gene cluster, that for moenomycin
production, is directly governed by two pleiotropic regula-
tors, one of which is likely to be also under the influence of
a third regulator. The described regulatory network is sum-
marized in figure 9. Here, two pleiotropic regulators AdpA
and BldA are involved in direct and multi-layered control
over moenomycin production, whereas another protein,
AbsB, limits AdpA abundance via ribonucleolytic activity.
We would like to underscore the reciprocity of functional
interactions enabling strict control over moenomycin pro-
duction. The pleiotropic transcriptional regulator AdpA
directly binds to the promoter regions of antibiotic biosyn-
thetic genes as well as its own promoter. BldA contributes
to the availability of developmentally regulated tRNALeuUAA,
the absence of which limits the translation of both adpA and
moe structural genes. Finally, absB-encodedRNaseIII influences
antibiotic production by modulating AdpA abundance in
addition to other, poorly understood way(s) evident from
our heterologous expression experiments. This kind of regulat-
ory network was initially elucidated in model streptomycetes,
S. coelicolor and S. griseus [39], where it also governs antibiotic
production. However, unlike these model cases, the influence
of the studied regulators on moenomycin production does
not appear to be mediated by CSRs.
According to available genomic data, absB, adpA and bldA
orthologues are omnipresent in Streptomyces genomes, pro-
viding the necessary foundation for their evolution as a
regulatory system that bypasses CSRs. Of the three regula-
tors, BldA directly regulating CSR-free pathways has been
extensively studied in other systems [21,47], while the invol-
vement of AdpA was most substantially confirmed in the
case of grisemycin biosynthesis [16,51]. The presence of
AdpA operator sequences in the promoters of structural
genes is another important indication of its role in the regulation
of CSR-free pathways. A cursory in silico analysis indicates that
the gene clusters for the biosynthesis of thiostrepton,
D5 J5 E5 F5 GT1 GT4 GT5 2 3H5 K5 M5 N5 O5 X5 P5 S5R5
moeO5 mRNAmoeE5 mRNA
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Figure 9. A model of the regulatory pathway that governs moenomycin biosynthesis in S. ghanaensis.
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8pacidamycin, albonoursin, acarbose and puromycin all contain
putative AdpA operator sequences within certain interge-
nic regions. Some of these clusters include structural genes
containing TTA codons as well (tunicamycin, albonoursin,
erythromycin and puromycin clusters). Echoing the idea put for-
ward by Higo et al. [24], we think that the low DNA-binding
specificity of AdpAmay be the key to the evolution of its control
over CSR-free antibiotic biosynthetic gene clusters. In fact, AdpA
was shown to form the largest bacterial regulon known to date
with over 500 genes under its direct control. AdpA, like no
other pleiotropic transcriptional factor of Streptomyces, would
therefore be capable of putting laterally acquired antibiotic bio-
synthesis gene clusters under growth phase-dependent control.
We note that another moenomycin biosynthetic gene cluster,
located within the giant plasmid pSCL4 of Streptomyces clavuli-
gerus ATCC27064 [52], may provide complementary evidence
for the importance of AdpA control over the secondary metabo-
lome. Despite numerous attempts, we failed to detect the
production of moenomycins by S. clavuligerus (B. Ostash 2012,
unpublished data). The moe gene clusters of S. ghanaensis and
S. clavuligerus are syntenous and respective (homologous) gene
products share 71–94% similarity [1]; yet, intergenic regions of
S. clavuligerus moe cluster do not contain AdpA-binding sites
(data not shown). It will be interesting to determine the distri-
bution of AdpA operators within silent gene clusters of
streptomycetes to further elucidate the role of AdpA in control
of the secondary metabolome.
The promoter region of tRNALeuUAA-encoding gene bldAgh
is under the transcriptional control of AdpAgh. However,
adpAgh contains one UUA codon in the middle of the coding
sequence, putting it under BldAgh translational control. In
S. coelicolor, S. griseus and S. clavuligerus [23,30,32,39] this con-
trol is very strict, while in S. ghanaensis DbldAgh AdpAgh is
still detected, albeit at a considerably decreased level.
AdpAgh mistranslation in the DbldAgh mutant could account
for this observation, which, to our knowledge, would be
the first case for the AdpA family of proteins. However in the
same S. ghanaensisDbldAgh strain, we failed to detect epimerase
MoeE5, which contains two TTA codons, indicating that mis-
translation of TTA codons does not occur 100% of the time in
the bldAgh-minus background.
The severe morphological defects of S. ghanaensis DbldAgh
vary under different growth conditions, which may contributeto AdpAgh expression. The complexity and conditionality of
the bldA phenotype is well known in S. coelicolor [53,54]. It is
the chief reason for ongoing debate as to whether bldA consti-
tutes a ‘true regulatory device’ [55,56] or just a ‘wiring’ of the
other regulatory networks [57,58]. Our data as well that of
Wang et al. [21] unequivocally demonstrate that a bldA deletion
directly abrogates the translation of UUA-containing tran-
scripts and, subsequently, antibiotic production. Hence, bldA
is a unique tRNA, absence of which indeed creates a regulatory
event in the form of infinite delay of the translation of UUAþ
transcripts. Recent work showed that, compared with the
more abundant tRNAs, accumulation of primary bldA tran-
script began at earlier stages, and BldA tRNA scaffold does
not determine its regulatory role [56]. Availability of mature
BldA may thus be regulated by posttrancriptional modifi-
cation, but no evidence for that is available. Function of BldA
is likely to be more conditional than that of transcriptonal fac-
tors, which might be manifested in the form of leaky
translation of UUA codons in the absence of cognate tRNA.
The leaky translation of AdpAgh in a DbldAgh background
provides some clues about the early stages of moenomycin
biosynthesis as well as morphological differentiation in
S. ghanaensis, when there would be little or no mature
tRNALeuUAA in the cells [18,39]. Just a small amount of
AdpAgh, available during early stages of growth in the absence
of BldAgh, could be sufficient to activate transcription from
bldAghp leading to an avalanche-like increase in bldAgh
expression. Once available, charged tRNALeuUAA could then
amplify the translation of adpAgh and other, as-yet-unknown,
UUAþ genes that lead to the downregulation of adpA and
moeE5 promoters. Our data confirm the presence of a regulat-
ory feedback loop that amplifies a signal in dual regulation
of BldA–AdpA in S. ghanaensis, as was previously shown in
S. griseus [39].
The increased transcription of adpAgh from constitutive
promoter ermE improved moenomycin production 2.5-fold
in spite of the fact that (as our work shows) it is the trans-
lation efficiency of UUA-containing adpAgh mRNA that
should determine the degree of activation of moe genes. At
the moment, we cannot fully explain our results although
several possible scenarios can be outlined. First, once the
charged tRNALeuUAA is available, it might eventually
lead to increased moenomycin production in the cells
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9overexpressing adpAgh compared with the wild-type cells
(note that we determine moenomycin production in the one
time-point, which represents the total moenomycin produced
over 72 h of growth). Second, if adpAgh mRNA is increased it
might increase the probability of its mistranslation; this may
also trigger moenomycin overproduction. Whatever the real
mechanism is, it is practically useful because antibiotic titre
improvement is a key requirement for the industry and it
was one of the motivations for this work. In the case of
CSR-free gene clusters, random mutagenesis and screening
remain the only practical means to improve secondary metab-
olite production [59]. Recombinant DNA technology has yet
to prove its utility for many industrial needs. Here, we
demonstrate that the regulatory network bldA–adpA–absB is
a cross-organism and large-effect system that can be har-
nessed to generate improved moenomycin producers. Upon
combining absBgh deletion and adpAgh overexpression in
S. ghanaensis, we observe, on average, a sevenfold increase
in moenomycin production (data not shown). We anticipate
that moenomycin titres can be further improved by bypass-
ing bldAgh regulation, through the elimination of TTA
codons from moe genes and adpAgh. Hence, genetic manipula-
tions of the genes studied here could be a component of
rational improvement of moenomycin producers. Recent
studies [60,61] and several lines of evidence discussed
above point to the fact that regulatory effects of adpA and
bldA on SM are widespread and this could be exploited in
other biosynthetic pathways. The amenability of SM to
rational manipulations is also highlighted by a recent
genome-wide study of the clavulanic acid overproducer, in
which it was found that a small number of genetic changes,
including AdpA overexpression, appeared to be associated
with the desired phenotype [62].5. Material and methods
5.1. Bacterial strains, plasmids and culture conditions
Strains andplasmids used in this studyare described in the elec-
tronic supplementary material, table S2. Escherichia coli strains
were grown in Luria-Bertani medium. Streptomyces strains
were grown on SM and oatmeal agar media and in TSB and
R2YE liquid media. Unless otherwise stated, S. ghanaensis was
grown at 378C and other streptomycetes at 308C, with shaking
at 200 r.p.m. All constructs were transferred into Streptomyces
conjugally. The presence and stability of inheritance of wC31-
based constructs in streptomycetes was checked as described
earlier [63,64].5.2. Procedures for DNA manipulation
Oligonucleotides used in this work are listed in the electronic
supplementary material, table S3. Standard procedures were
used for plasmid/chromosomal DNA isolation, subcloning
and analysis [65]. Polymerase chain reactions (PCRs) were per-
formed using recombinant Pfu DNA polymerase (Fermentas)
and all PCR products were sequenced. RedET-mediated gene
replacements in cosmids and plasmids were carried out with
the help of REDIRECT system [66]. All constructs were verified
by sequencing, PCR or restriction mapping.5.3. Quantitative analysis of moenomycins production
Growth of the strains, moenomycin extraction, conditions of
LC-MS and quantitative analysis of the data are described by
Ostash et al. [2] and Makitrynskyy et al. [10]. The levels of moe-
nomycin production were calculated from at least three
independent experiments and referred back to equal amounts
of dry biomass (10 mg) in different strains. The cells were
exhaustively extracted three times; the fourth extraction did
not contain anymeasurable amounts ofmoenomycins confirm-
ing that all moenomycin had already been recovered (data not
shown). The following compoundsweremonitored via LC/MS
in S. ghanaensis extracts: MmA ([M-H]2 ¼ 1580.6 Da) and noso-
komycin B (NoB; [M-H]2 ¼ 1484.6 Da). The mixture of these
two equidominant compounds [64] is referred to as moenomy-
cin in this work. Cosmid moeno38-5 directs the biosynthesis of
nosokomycin B1 (NoB1; [M-H]
2¼ 1500.6 Da) and its production
was followed in the extracts of heterologous hosts (S. lividans and
S. coelicolor). LC/MS data were acquired on Agilent 1110 LC/
MSD and Bruker Esquire 3000 ESI-MS spectrometers.
5.4. Identification of AdpAgh-binding sites
To identify conserved AdpA-binding sites (AdpAbs) in
S. ghanaensis, known AdpAbs sequences were collected
from GenBank. This dataset was used as input for the
MEME software tool [67] to search for the consensus motif.
Search for the occurrence of the identified motif within moe
clusters, bldAgh and adpAgh promoter regions was performed
using FIMO software suite [68].
5.5. Semiquantitative RT-PCR
Mycelia of S. ghanaensis were harvested in moenomycin pro-
ductionphase (72 h) andprocessedasdescribedpreviously [10].
5.6. Construction of the Streptomyces ghanaensis
DabsBgh and plasmids for complementation
experiments
A construct for absBgh knockout was prepared as follows. A
2.5 kb DNA fragment containing absBgh and its flanking
regions were amplified from S. ghanaensis genomic DNA by
PCR using primers absBgh_kn_for and absBgh_kn_rev. The
PCR product was ligated to SmaI-digested pBluescriptKSþ
to yield pBlabsBgh-kn. The loxP site-flanked apramycin resist-
ance cassette (aac(3)IV) from plasmid pLERECJ was amplified
with primers red_absBgh_kn_for and red_absBgh_kn_rev. The
resulting amplicon was used to replace the coding sequence of
absBgh in pBlabsBgh-kn via recombineering, giving pBlabsBgh-
kn::aac(3)IV. The latter was digested with BamHI and EcoRI
and the fragment containing the absBgh::aac(3)IV mutant allele
was cloned into the same sites of pKC1139Km to yield
pKCabsB-kn::aac3(IV). Streptomyces ghanaensis transconjugants
carrying the latter were selected for resistance to apramy-
cin (25 mg ml21). To generate S. ghanaensis single-crossover
AmrKmr mutants, initial transconjugants were incubated at
408C for 5 days, and then screened for apramycin resistance
and kanamycin sensitivity (an indicative of vector loss and
double crossover). Replacement of absBgh with aac(3)IV in
S. ghanaensis DabsBgh::aac(3)IVwas confirmed by PCR (primers
absBgh_ex_for and absBgh_ex_rev; data not shown). The
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10Cre-expressing helper plasmid pUWLCrewas then introduced
into S. ghanaensis DabsBgh::aac(3)IV to evict aac(3)IV from its
genome. The pUWLCreþ transconjugants resistant to tiostrep-
ton were incubated on oatmeal agar plates and selected for
apramycin sensitivity. The helper plasmid was lost after two
subsequent passages of selected Ams clone in the absence of
thiostrepton. Excision of aac(3)IV from the S. ghanaensisDabsBgh
genome was confirmed by PCR (primers absBgh_ex_for and
absBgh_ex_rev; data not shown).
A set of plasmids containing absBgh gene along with its
upstream region of different lengths (figure 1) was constructed
for complementation analysis. To create a plasmid pSO-
KabsBgh-exp, a 1.1 kb fragment carrying entire absBgh with its
150 bp 50-region was amplified from S. ghanaensis genomic
DNA using primers absBgh_ex_for and absBgh_ex_rev. The
obtained amplicon was cloned into integrative VWB-based
vector pSOK804 digestedwith EcoRV to give pSOKabsBgh-exp.
To construct plasmid pSOKEabsBgh-exp, where tran-
scription of absBgh is under ermEp control, the above 1.1 kb
PCR fragment was first cloned into EcoRV-treated
pKC1218E, yielding pKCEabsBgh-exp. Then pKCEabsBgh-
exp was digested with HindIII and EcoRI and 1.4 kb DNA
fragment harbouring absBgh plus ermEp was ligated to
pSOK804, digested with respective endonucleases, to gener-
ate pSOKEabsBgh-exp.
To create a plasmid pSOKabsBgh-II encompassing two
genes, SSFG_02130.1 and SSFG_02129.1 (absBgh), along with
the 200 bp upstream region, a 1.4 kb DNA fragment was
amplified using primers absB-gh-II-for and absB-gh-II-rev.
The resulting amplicon was cloned into EcoRV-treated
pSOK804 to give pSOKabsBgh-II.
Plasmid pSOKabsBgh-III is based on pSOK804 and carries
a 2.2 kb DNA fragment containing three genes, SSFG_
02131.1, SSFG_02130.1 and SSFG_02129.1 (absBgh), along with
the 250 bp upstream region. It was constructed by cloning
an amplicon generated with primers absB-gh-I_I-for and
absB-gh-I_I-rev into EcoRV site of pSOK804.
5.7. Construction of the Streptomyces ghanaensis
DadpAgh and plasmid for complementation
experiment
A 3.5 kb DNA fragment containing adpAgh and its flanking
regions was amplified from the chromosome of S. ghanaensis
using primers adpA_kn_for and adpA_kn_rev. The resulting
amplicon was ligated to EcoRV-digested pBluescriptKSþ to
yield pBladpAkn. To replace adpAgh the aac(3)IV cassette
from pLERECJ was amplified using primers adpA_red_for
and adpA_red_rev, and the resulting amplicon was used
for recombineering-mediated replacement of adpAgh within
pBladpAkn to give pBladpA-kn::aac(3)IV. The latter was
further used as a template in PCR for amplification (primers
adpA_kn_for and adpA_kn_rev) of a 3.4 kb DNA fragment
harbouring DadpAgh::aac(3)IV. The obtained amplicon was
cloned into EcoRV-digested vector pKC0702. The final adpAgh
knockout plasmid was labelled pKCHadpA-kn::aac(3)IV.
Generation of DadpAgh mutant was carried out as described
above. Mutant phenotype of S. ghanaensis DadpAgh::aac(3)IV
was confirmed by PCR using primers adpA_exp_for and
adpA_exp_rev. Generation and verification of aac(3)IV-evicted
strain DadpAgh was carried out as described for DabsBgh strain
(primers adpA_for and adpA_rev; data not shown).For the complementation of S. ghanaensis DadpAgh, a 1.9 kb
fragment carrying adpAgh with its promoter region was ampli-
fied with primers adpA_for and adpA_rev_compl. The
resulting amplicon was digested with XbaI and EcoRV and
cloned into respective sites of pSET152, to give pSETadpA-exp.
For adpAgh expression under ermEp control, a 1.4 kb
fragment containing only the coding sequence of adpAgh was
amplified with primers adpA_exp_for and adpA_exp_rev.
The amplicon was digested with EcoRV and EcoRI and ligated
to EcoRV–EcoRI-linearized pTES to generate pTESaadpa-exp.
5.8. Construction of the DbldAgh strain and plasmid
for complementation experiment
The 2.0 kb S. ghanaensis genomic regions flanking bldAgh were
amplified with primers bldA-left-up plus bldA-left-rp
(‘left’ homology arm) and bldA-right-up plus bldA-right-rp
(‘right’ arm). ‘Left’ and ‘right’ amplicons were digested with
HindIII þ XbaI and XbaIþ EcoRI, respectively, and cloned
into HindIII–EcoRI-digested pKC1139. The resulting bldAgh
knockout plasmid pKC1139bldA-del contains markerless
deletion of the 87 bp bldAgh coding sequence. Manipulations
of pKC1139bldA-delþ transconjugants to generate the bldAgh
knockout strain were essentially the same as described above,
except that double crossover clones were screened among
those displaying impaired sporulation, as no antibiotic selec-
tion was possible. Diagnostic PCR with primers bldAXbaIup
and bldA-diagn-rp and sequencing confirmed the deletion of
the 87 bp bldAgh sequence from the genome of DbldAgh. For
complementation and expression experiments, the bldAgh
coding region along with the 320 bp upstream segment was
amplified with primers bldAXbaIup and bldAEcoRIrp and
cloned into respective sites of pSET152 to yield pSET152bldA.
5.9. Construction of GusA reporter plasmids and
b-glucuronidase activity measurements
To probe the activities of moeE5, absBgh, adpAgh and bldAgh pro-
moters, DNA fragments containing putative promoter regions
(500 bp upstream of the translation start codons) were amplified
byPCRusingupstreamprimers carrying anXbaI site anddown-
stream primers carrying a KpnI site (primers moeE5_for and
moeE5_script_rev for moeE5p; absB_for and absB_script_rev
for absBghp; adpA_for and adpA_script_rev for adpAghp; bldA_
for and bldA_script_rev for bldAghp). The moeE5p, absBghp,
adpAghp and bldAghp fragments were cloned into XbaI–KpnI-
digested pGUS, to give plasmids pmoeE5script, pabsBscript,
padpAscript and pbldAscript, respectively.
To investigate the expression of moeE5 and adpAgh on the
translational level, DNA fragments containing the entire stop
codon-free genes with putative promoter (500 bp upstream of
the translation start codons) were amplified by PCR using
upstream primers carrying XbaI site and downstream pri-
mers carrying an EcoRV site (primers moeE5_for and
moeE5_rev for moeE5; adpA_for and adpA_rev for adpAgh).
The moeE5 and adpAgh fragments were cloned into XbaI–
EcoRV-digested pGUSHL4aadA [36], an integrative Strepto-
myces vector where the examined gene is fused to the gusA
reporter gene through the helical linker HL4 [69], yielding
pmoeE5transl and padpAtransl, respectively. In control
experiments, promoterless moeE5 and adpAgh genes without
stop codon were amplified by PCR using upstream primers
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11carrying XbaI site and downstream primers carrying EcoRV
site (primers moeE5_for_contr and moeE5_rev for moeE5;
adpA_for_contr and adpA_rev for adpAgh) and cloned in
XbaI–EcoRV-treated pGUSHL4aadA, giving pmoeE5contr
and padpAcontr, respectively.
The spore suspensions (2  105 cfu) of streptomycetes
reporter plasmid-bearing strains were inoculated in 300 ml
flasks with 100 ml of TSB, and grown for 30 h. One millilitre
of the preculture was inoculated into fresh TSB medium
(100 ml) and grown for 24–28 h (depending on experiment).
Mycelium was harvested, washed twice with distilled water,
then resuspended in lysis buffer (50 mM phosphate buffer
(pH 7.0), 0.1% Triton X-100, 5 mM DTT, 4 mg ml21 lyso-
zyme) and incubated for 30 min at 378C. Lysates were
centrifuged for 10 min at 5000 r.p.m. Then, 0.5 ml of lysate
was mixed with 0.5 ml of dilution buffer (50 mM phosphate
buffer (pH 7.0), 5 mM DTT, 0.1% Triton X-100) supplemented
with 5 ml 0.2 M p-nitrophenyl-b-D-glucuronide and used for
measuring optical density at l ¼ 415 nm every minute
during 20 min of incubation at 378C. As a reference, a 1 : 1
mixture of lysate and dilution buffer was used.
5.10. Expression and purification of His-tagged AdpAgh
For the production of C-terminal hexahistidine-tagged
AdpAgh, the coding region of gene adpAgh was amplified
with primers AdpA_pr_for and AdpA_pr_rev from S. gha-
naensis chromosomal DNA. PCR product was purified and
cloned into NcoI–XhoI cloning sites of expression vector
pET24b, giving pETAdpAgh.
Escherichia coli BL21-GOLD cells harbouring the pETAd-
pAgh were grown in YTB medium containing 50 mgml–1
ampicillin and kanamycin until The OD600 reached 0.8–1.0.
Expression of AdpAgh was induced with 0.4 mM IPTG at
208C for 16–18 h. After incubation, cells were harvested by cen-
trifugation and lysed in wash buffer (50 mM sodium
phosphate, 300 mM sodium chloride) by French press. As
AdpAgh was expressed in both soluble and insoluble fractions,
the lysate without centrifugation was directly mixed with
Cobalt affinity resin. Purification of the protein was performed
according to TALON Metal Affinity Resin manual (Clontech).
The resin with attached protein was loaded on a column,
washed with PBS. AdpAgh was eluted with PBS containing
150 mM imidazole. Aliquots were examined using SDS-
polyacrylamide gel electrophoresis and Coomassie blue stain-
ing. The eluted fraction was washed from imidazole by
dialysis with a storage buffer (50 mM disodium hydrogen
phosphate, 300 mM sodium chloride, 1 mM EDTA, 25%
glycerol, pH ¼ 7). Purified AdpAgh samples were stored at–208C in storage buffer. Protein concentration was determined
according to the Bio-Rad DC Protein Assay.
5.11. Gel electrophoretic mobility shift assay
The 500 bp promoter regions of the targeted genes (adpAgh,
bldAgh, moeE5, moeK5, moeO5) were used in EMSA. These
probeswere amplified from chromosomalDNAof S. ghanaensis
by PCR using primers adpA_for and adpA_script_rev for
adpAgh; bldA_for and bldA_script_rev for bldAgh; moeE5_for
and moeE5_script_rev for moeE5; moeK5_for and moeK5_
script_rev for moeK5; moeO5_for and moeO5_script_rev for
moeO5 (see the electronic supplementary material, table S3). A
total of 10 pmol of each probe was 50-end labelled with
20 pmol [g-32P] using T4 polynucleotide kinase according
to established protocols (Fermentas). Unincorporated labelled
dATP was removed using ProbeQuant G-50 Micro columns
(GE Healthcare). A total of 20 fmol of labelled probe was incu-
bated with purified 1.1, 4.4, 11, 22, 44, 88 pM His-tagged
AdpAgh at 258C for 15 min in 15 ml binding buffer (20 mM
Tris–HCl (pH 8.0), 1 mM EDTA, 1 mM DTT, 100 mM KCl,
10 mM MgCl2, 10% glycerol) containing 1 mg of poly(dI-dC).
The reactions products (protein-bound and free DNA)
were separated on 4% non-denaturing polyacrylamide gel in
TBE-buffer. The gels were visualized by phosphorimaging.
5.12. Western blotting MoeE5
Plasmid and conditions for expression and purification of
N-terminal thioredoxin/His6-tagged MoeE5 protein in E. coli
were previously described [2]. Purified recombinant MoeE5
proteinwasusedas antigen to raise antibodies in a rabbit (asper-
formed by Jackson ImmunoResearch laboratories (West Grove,
PA, USA)). The same batch of S. ghanaensis mycelia was used
for RT-PCR andWestern blot analysis. Briefly, biomass samples
were taken from2808C, thawedon ice andresuspended insmall
volume of PBS. The mixture was French-pressed three times,
centrifuged and supernatant taken for further analysis. Twenty
microgram protein samples were separated in 7.5% SDS-
polyacrylamide gels and upon blotting were probed with a
1 : 1000 dilution of the primary antiserum.
Acknowledgements. The content is solely the responsibility of the authors
and does not necessarily represent the official views of the NIH. We
are grateful to Eriko Takano for providing the S. coelicolorM851 strain
and Jason Sello for S. coelicolor J3410; Nestor Zaburannyy is thanked
for help in screening of AdpAbs.
Funding statement. The work was supported by grant Bg-98F from the
Ministry of Education and Science (to V.F.), by NIH grants
2P01AI083214-04 (to S.W.) and R03TW009424 (to V.F. and S.W.).
R.M. and B.O. were supported by DAAD fellowships.References1. Ostash B, Walker S. 2010 Moenomycin family
antibiotics: chemical synthesis, biosynthesis, and
biological activity. Nat. Prod. Rep. 27, 1594–1617.
(doi:10.1039/c001461n)
2. Ostash B, Doud EH, Lin C, Ostash I, Perlstein DL,
Fuse S, Wolpert M, Kahne D, Walker S.
2009 Complete characterization of the seventeen
step moenomycin biosynthetic pathway.Biochemistry 48, 8830–8841. (doi:10.1021/
bi901018q)
3. van Wezel GP, McDowall KJ. 2011 The regulation of
the secondary metabolism of Streptomyces: new
links and experimental advances. Nat. Prod. Rep.
28, 1311–1333. (doi:10.1039/c1np00003a)
4. Liu G, Chater KF, Chandra G, Niu G, Tan H. 2013
Molecular regulation of antibiotic biosynthesis inStreptomyces. Microbiol. Mol. Biol. Rev. 77,
112–143. (doi:10.1128/MMBR.00054-12)
5. McKenzie NL, Nodwell JR. 2007 Phosphorylated
AbsA2 negatively regulates antibiotic production in
Streptomyces coelicolor through interactions with
pathway-specific regulatory gene promoters.
J. Bacteriol. 189, 5284–5292. (doi:10.1128/JB.
00305-07)
rsob.royalsocietypublishing.org
Open
Biol3:130121
126. Huang J et al. 2005 Cross-regulation among
disparate antibiotic biosynthetic pathways of
Streptomyces coelicolor. Mol. Microbiol. 58, 1276–
1287. (doi:10.1111/j.1365-2958.2005.04879.x)
7. Rodriguez M, Nu´n˜ez LE, Bran˜a AF, Me´ndez C, Salas
JA, Blanco G. 2008 Identification of transcriptional
activators for thienamycin and cephamycin C
biosynthetic genes within the thienamycin gene
cluster from Streptomyces cattleya. Mol. Microbiol.
69, 633–645. (doi:10.1111/j.1365-2958.2008.
06312.x)
8. Baltz RH. 2011 Strain improvement in
actinomycetes in the postgenomic era. J. Ind.
Microbiol. Biotechnol. 38, 657–666. (doi:10.1007/
s10295-010-0934-z)
9. Ostash B, Saghatelian A, Walker S. 2007 A
streamlined metabolic pathway for the biosynthesis
of moenomycin A. Chem. Biol. 14, 257–267.
(doi:10.1016/j.chembiol.2007.01.008)
10. Makitrynskyy R, Rebets Y, Ostash B, Zaburannyi N,
Rabyk M, Walker S, Fedorenko V. 2010 Genetic
factors that influence moenomycin production in
streptomycetes. J. Ind. Microbiol. Biotechnol. 37,
559–566. (doi:10.1007/s10295-010-0701-1)
11. Cortes J, Haydock SF, Roberts GA, Bevitt DJ, Leadlay
PF. 1990 An unusually large multifunctional
polypeptide in the erythromycin-producing
polyketide synthase of Saccharopolyspora erythraea.
Nature 348, 176–178. (doi:10.1038/348176a0)
12. Donadio S, Staver MJ, McAlpine JB, Swanson SJ,
Katz L. 1991 Modular organization of genes
required for complex polyketide biosynthesis.
Science 252, 675–679. (doi:10.1126/science.
2024119)
13. Kelly WL, Pan L, Li C. 2009 Thiostrepton
biosynthesis: prototype for a new family of
bacteriocins. J. Am. Chem. Soc. 131, 4327–4334.
(doi:10.1021/ja807890a)
14. Wyszynski FJ, Hesketh AR, Bibb MJ, Davis BG. 2010
Dissecting tunicamycin biosynthesis by genome
mining: cloning and heterologous expression of a
minimal gene cluster. Chem. Sci. 1, 581–589.
(doi:10.1039/C0SC00325E)
15. Zhang W, Ostash B, Walsh CT. 2010 Identification of
the biosynthetic gene cluster for the pacidamycin
group of peptidyl nucleoside antibiotics. Proc. Natl
Acad. Sci. USA 107, 16 828–16 833. (doi:10.1073/
pnas.1011557107)
16. Claesen J, Bibb MJ. 2011 Biosynthesis and
regulation of grisemycin, a new member of the
linaridin family of ribosomally synthesized peptides
produced by Streptomyces griseus IFO 13350.
J. Bacteriol. 193, 2510–2516. (doi:10.1128/JB.
00171-11)
17. Zaburannyy N, Ostash B, Fedorenko V. 2009 TTA
Lynx: a web-based service for analysis of
actinomycete genes containing rare TTA codon.
Bioinformatics 25, 2432–2433. (doi:10.1093/
bioinformatics/btp402)
18. Leskiw BK, Mah R, Lawlor EJ, Chater KF. 1993
Accumulation of bldA specified tRNA is temporally
regulated in Streptomyces coelicolor A3(2).
J. Bacteriol. 175, 1995–2005.19. Chater KF, Chandra G. 2008 The use of the rare UUA
codon to define ‘expression space’ for genes
involved in secondary metabolism, development
and environmental adaptation in streptomyces.
J. Microbiol. 46, 1–11. (doi:10.1007/s12275-
007-0233-1)
20. Chandra G, Chater KF. 2008 Evolutionary flux of
potentially bldA-dependent Streptomyces genes
containing the rare leucine codon TTA. Antonie Van
Leeuwenhoek 94, 111–126. (doi:10.1007/s10482-
008-9231-5)
21. Wang J, Schully KL, Pettis GS. 2009 Growth-
regulated expression of a bacteriocin, produced by
the sweet potato pathogen Streptomyces ipomoeae,
that exhibits interstrain inhibition. Appl. Environ.
Microbiol. 75, 1236–1242. (doi:10.1128/AEM.
01598-08)
22. Ohnishi Y, Kameyama S, Onaka H, Horinouchi S.
1999 The A-factor regulatory cascade leading to
streptomycin biosynthesis in Streptomyces griseus:
identification of a target gene of the A-factor
receptor. Mol. Microbiol. 34, 102–111. (doi:10.
1046/j.1365-2958.1999.01579.x)
23. Takano E et al. 2003 A rare leucine codon in adpA is
implicated in the morphological defect of bldA
mutants of Streptomyces coelicolor. Mol. Microbiol.
50, 475–486. (doi:10.1046/j.1365-2958.2003.
03728.x)
24. Higo A, Hara H, Horinouchi S, Ohnishi Y. 2012
Genome-wide distribution of AdpA, a global
regulator for secondary metabolism and
morphological differentiation in Streptomyces,
revealed the extent and complexity of the AdpA
regulatory network. DNA Res. 19, 259–273.
(doi:10.1093/dnares/dss010)
25. Xu W, Huang J, Lin R, Shi J, Cohen SN. 2010
Regulation of morphological differentiation in
S. coelicolor by RNase III (AbsB) cleavage of mRNA
encoding the AdpA transcription factor. Mol.
Microbiol. 75, 781–791. (doi:10.1111/j.1365-2958.
2009.07023.x)
26. Ohnishi Y, Yamazaki H, Kato J-Y, Tomono A,
Horinouchi S. 2005 AdpA, a central transcriptional
regulator in the A-factor regulatory cascade that
leads to morphological development and secondary
metabolism in Streptomyces griseus. Biosci.
Biotechnol. Biochem. 69, 431–439. (doi:10.1271/
bbb.69.431)
27. Horinouchi S. 2007 Mining and polishing of the
treasure trove in the bacterial genus Streptomyces.
Biosci. Biotechnol. Biochem. 71, 283–299. (doi:10.
1271/bbb.60627)
28. Akanuma G, Hara H, Ohnishi Y, Horinouchi S.
2009 Dynamic changes in the extracellular
proteome caused by absence of a pleiotropic
regulator AdpA in Streptomyces griseus. Mol.
Microbiol. 73, 898–912. (doi:10.1111/j.1365-2958.
2009.06814.x)
29. Wolan´ski M, Jakimowicz D, Zakrzewska-Czerwin´ska
J. 2012 AdpA, key regulator for morphological
differentiation regulates bacterial chromosome
replication. Open Biol. 2, 120097. (doi:10.1098/
rsob.120097)30. Nguyen KT, Tenor J, Stettler H, Nguyen LT,
Nguyen LD, Thompson CJ. 2003 Colonial
differentiation in Streptomyces coelicolor depends on
translation of a specific codon within the adpA
gene. J. Bacteriol. 185, 7291–7296. (doi:10.1128/
JB.185.24.7291-7296)
31. Zhu D, He X, Zhou X, Deng Z. 2005 Expression of
the melC operon in several Streptomyces strains is
positively regulated by AdpA, an AraC family
transcriptional regulator involved in morphological
development in Streptomyces coelicolor. J. Bacteriol.
187, 3180–3187. (doi:10.1128/JB.187.9.3180-
3187.2005)
32. Lo´pez-Garcı´a MT, Santamarta I, Liras P. 2010
Morphological differentiation and clavulanic acid
formation are affected in a S. clavuligerus adpA-
deleted mutant. Microbiology 156, 2354–2365.
(doi:10.1099/mic.0.035956-0)
33. Yamazaki H, Tomono A, Ohnishi Y, Horinouchi S.
2004 DNA-binding specificity of AdpA, a
transcriptional activator in the A-factor regulatory
cascade in Streptomyces griseus. Mol. Microbiol. 53,
555–572. (doi:10.1111/j.1365-2958.2004.04153.x)
34. Hopwood DA, Wildermuth H, Palmer HM. 1970
Mutants of Streptomyces coelicolor defective in
sporulation. J. Gen. Microbiol. 61, 397–408.
(doi:10.1099/00221287-61-3-397)
35. Du YL, Li SZ, Zhou Z, Chen SF, Fan WM, Li YQ. 2011
The pleiotropic regulator AdpAch is required for
natamycin biosynthesis and morphological
differentiation in Streptomyces chattanoogensis.
Microbiology 157, 1300–1311. (doi:10.1099/mic.0.
046607-0)
36. Myronovskyi M, Welle E, Fedorenko V, Luzhetskyy A.
2011 Beta-glucuronidase as a sensitive and versatile
reporter in actinomycetes. Appl. Environ. Microbiol.
77, 5370–5383. (doi:10.1128/AEM.00434-11)
37. Passantino R, Puglia A-M, Chater K. 1991 Additional
copies of the actII regulatory gene induce
actinorhodin production in pleiotropic bld
mutants of Streptomyces coelicolor A3(2). J. Gen.
Microbiol. 137, 2059–2064. (doi:10.1099/
00221287-137-9-2059)
38. Guthrie EP, Flaxman CS, White J, Hodgson DA, Bibb
MJ, Chater KF. 1998 A response-regulator-like
activator of antibiotic synthesis from Streptomyces
coelicolor A3(2) with an amino-terminal domain
that lacks a phosphorylation pocket. Microbiology
144, 727–738. (doi:10.1099/00221287-144-3-727)
39. Higo A, Horinouchi S, Ohnishi Y. 2011 Strict
regulation of morphological differentiation and
secondary metabolism by a positive feedback loop
between two global regulators AdpA and BldA in
Streptomyces griseus. Mol. Microbiol. 81, 1607–1622.
(doi:10.1111/j.1365-2958.2011.07795.x)
40. Wolan´ski M, Donczew R, Kois-Ostrowska A,
Masiewicz P, Jakimowicz D, Zakrzewska-Czerwinska
J. 2011 The level of AdpA directly affects expression
of developmental genes in Streptomyces coelicolor.
J. Bacteriol. 193, 6358–6365. (doi:10.1128/JB.
05734-11)
41. Sello JK, Buttner MJ. 2008 The gene encoding
RNase III in Streptomyces coelicolor is transcribed
rsob.royalsocietypublishing.org
Open
Biol3:130121
13during exponential phase and is required for
antibiotic production and for proper sporulation.
J. Bacteriol. 190, 4079–4083. (doi:10.1128/JB.
01889-07)
42. Pan Y, Liu G, Yang H, Tian Y, Tan H. 2009 The
pleiotropic regulator AdpA-L directly controls the
pathway-specific activator of nikkomycin
biosynthesis in Streptomyces ansochromogenes. Mol.
Microbiol. 72, 710–723. (doi:10.1111/j.1365-2958.
2009.06681.x)
43. Bibb MJ. 2005 Regulation of secondary metabolism
in streptomycetes. Curr. Opin. Microbiol. 8,
208–215. (doi:10.1016/j.mib.2005.02.016)
44. Oliynyk M, Samborskyy M, Lester JB, Mironenko T,
Scott N, Dickens S, Haydock SF, Leadlay PF. 2007
Complete genome sequence of the erythromycin-
producing bacterium Saccharopolyspora erythraea
NRRL23338. Nat. Biotechnol. 25, 447–453.
(doi:10.1038/nbt1297)
45. Lautru S, Gondry M, Genet R, Pernodet JL. 2002 The
albonoursin gene cluster of Streptomyces noursei
biosynthesis of diketopiperazine metabolites
independent of nonribosomal peptide synthetases.
Chem. Biol. 9, 1355–1364. (doi:10.1016/S1074-
5521(02)00285-5)
46. Li C, Kelly WL. 2010 Recent advances in thiopeptide
antibiotic biosynthesis. Nat. Prod. Rep. 27,
153–164. (doi:10.1039/b922434c)
47. Tercero JA, Espinosa JC, Jime´nez A. 1998 Expression
of the Streptomyces alboniger pur cluster in
Streptomyces lividans is dependent on the bldA-
encoded tRNALeu. FEBS Lett. 421, 221–223.
(doi:10.1016/S0014-5793(97)01564-0)
48. Rackham EJ, Gru¨schow S, Ragab AE, Dickens S, Goss
RJ. 2010 Pacidamycin biosynthesis: identification
and heterologous expression of the first uridyl
peptide antibiotic gene cluster. Chembiochem 11,
1700–1709. (doi:10.1002/cbic.201000200)
49. Wehmeier UF, Piepersberg W. 2004 Biotechnology
and molecular biology of the alpha-glucosidase
inhibitor acarbose. Appl. Microbiol. Biotechnol. 63,
613–625. (doi:10.1007/s00253-003-1477-2)
50. Yu Y et al. 2005 Gene cluster responsible for
validamycin biosynthesis in Streptomyces
hygroscopicus subsp. jinggangensis 5008. Appl.Environ. Microbiol. 71, 5066–5076. (doi:10.1128/
AEM.71.9.5066-5076)
51. Hara H, Ohnishi Y, Horinouchi S. 2009 DNA
microarray analysis of global gene regulation by
A-factor in Streptomyces griseus. Microbiology 155,
2197–2210. (doi:10.1099/mic.0.027862-0)
52. Medema MH et al. 2010 The sequence of a 1.8-mb
bacterial linear plasmid reveals a rich evolutionary
reservoir of secondary metabolic pathways. Genome
Biol. Evol. 2, 212–224. (doi:10.1093/gbe/evq013)
53. Lawlor EJ, Baylis HA, Chater KF. 1987 Pleiotropic
morphological and antibiotic deficiencies result from
mutations in a gene encoding a tRNA-like product
in Streptomyces coelicolor A3(2). Genes Dev. 1,
1305–1310. (doi:10.1101/gad.1.10.1305)
54. Leskiw BK, Lawlor EJ, Fernandez-Abalos JM, Chater KF.
1991 TTA codons in some genes prevent their
expression in a class of developmental, antibiotic-
negative, Streptomyces mutants. Proc. Natl Acad. Sci.
USA 88, 2461–2465. (doi:10.1073/pnas.88.6.2461)
55. den Hengst CD, Tran NT, Bibb MJ, Chandra G,
Leskiw BK, Buttner MJ. 2010 Genes essential for
morphological development and antibiotic
production in Streptomyces coelicolor are targets of
BldD during vegetative growth. Mol. Microbiol. 78,
361–379. (doi:10.1111/j.1365-2958.2010.07338.x)
56. Pettersson BM, Kirsebom LA. 2011 tRNA
accumulation and suppression of the bldA
phenotype during development in Streptomyces
coelicolor. Mol. Microbiol. 79, 1602–1614.
(doi:10.1111/j.1365-2958.2011.07543.x)
57. Gramajo HC, Takano E, Bibb MJ. 1993 Stationary-
phase production of the antibiotic actinorhodin in
Streptomyces coelicolor A3(2) is transcriptionally
regulated. Mol. Microbiol. 7, 837–845. (doi:10.
1111/j.1365-2958.1993.tb01174.x)
58. Hodgson DA. 2000 Primary metabolism and its
control in streptomycetes: a most unusual group of
bacteria. Adv. Microb. Physiol. 42, 47–238. (doi:10.
1016/S0065-2911(00)42003-5)
59. Endler K, Schuricht U, Hennig L, Welzel P, Holst U,
Aretz W, Bottger D, Huber G. 1998 Exploratory
investigations into the biosynthesis of the antibiotic
moenomycin A. Tetrahedron Lett. 39, 13–16.
(doi:10.1016/S0040-4039(97)10456-7)60. Tan GY, Bai L, Zhong JJ. 2013 Exogenous 1,4-
butyrolactone stimulates A-factor-like cascade and
validamycin biosynthesis in Streptomyces
hygroscopicus 5008. Biotechnol. Bioeng. 110,
2984–2993. (doi:10.1002/bit.24965)
61. Lee HN, Kim JS, Kim P, Lee HS, Kim ES. 2013
Repression of antibiotic down-regulator WblA by
AdpA in Streptomyces coelicolor. Appl. Environ.
Microbiol. 79, 4159–4163. (doi:10.1128/AEM.
00546-13)
62. Medema MH, Alam MT, Heijne WH, van den Berg
MA, Mu¨ller U, Trefzer A, Bovenberg RA, Breitling R,
Takano E. 2011 Genome-wide gene expression
changes in an industrial clavulanic acid
overproduction strain of Streptomyces clavuligerus.
Microb. Biotechnol. 4, 300–305. (doi:10.1111/j.
1751-7915.2010.00226.x)
63. Ostash B, Makitrinskyy R, Walker S, Fedorenko V.
2009 Identification and characterization of
Streptomyces ghanaensis ATCC14672 integration
sites for three actinophage-based plasmids. Plasmid
61, 171–175. (doi:10.1016/j.plasmid.2008.12.002)
64. Ostash B, Doud E, Walker S. 2012 ABC transporter
genes from Streptomyces ghanaensis moenomycin
biosynthetic gene cluster: roles in antibiotic
production and export. Arch Microbiol 194, 915–
922. (doi:10.1007/s00203-012-0827-9)
65. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular
cloning. A laboratory manual. Cold Spring Harbor,
NY: Cold Spring Harbor Laboratory Press.
66. Gust B. 2009 Cloning and analysis of natural
product pathways. Methods Enzymol. 458, 159–
180. (doi:10.1016/S0076-6879(09)04807-1)
67. Bailey TL, Elkan C. 1994 Fitting a mixture model by
expectation maximization to discover motifs in
biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2,
28–36.
68. Grant CE, Bailey TL, Noble WS. 2011 FIMO: Scanning
for occurrences of a given motif. Bioinformatics
27, 1017–1018. (doi:10.1093/bioinformatics/
btr064)
69. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T.
2001 Design of the linkers which effectively separate
domains of a bifunctional fusion protein. Protein Eng.
14, 529–532. (doi:10.1093/protein/14.8.529)
